本頁面由Tiger Trade Technology Pte. Ltd.提供服務

傳奇生物

18.64
-0.5500-2.87%
盤後18.850.2100+1.13%19:38 EDT
成交量:427.94萬
成交額:8,023.36萬
市值:36.25億
市盈率:-37.22
高:19.85
開:19.48
低:18.61
收:19.19
52周最高:37.50
52周最低:16.24
股本:1.94億
流通股本:9,134.12萬
量比:3.10
換手率:4.69%
股息:- -
股息率:- -
每股收益(TTM):-0.5008
每股收益(LYR):-1.6200
淨資產收益率:-8.08%
總資產收益率:-1.92%
市淨率:2.95
市盈率(LYR):-11.51

資料載入中...

2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/11

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/30

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/16

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/09

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/02

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/04

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/06/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/29

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers